A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma

Most anticancer drugs entering clinical trials fail to achieve approval from the US FDA. Drug development is hampered by the lack of preclinical models with therapeutic predictive value. Herein, we report the development and validation of a tumorgraft model of renal cell carcinoma (RCC) and its appl...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Sivanand, Sharanya, Peña-Llopis, Samuel, Zhao, Hong, Kucejova, Blanka, Spence, Patrick, Pavia-Jimenez, Andrea, Yamasaki, Toshinari, McBride, David J., Gillen, Jessica, Wolff, Nicholas C., Morlock, Lorraine, Lotan, Yair, Raj, Ganesh V., Sagalowsky, Arthur, Margulis, Vitaly, Cadeddu, Jeffrey A., Ross, Mark T., Bentley, David R., Kabbani, Wareef, Xie, Xian-Jin, Kapur, Payal, Williams, Noelle S., Brugarolas, James
Format: Artigo
Sprog:Inglês
Udgivet: 2012
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3570965/
https://ncbi.nlm.nih.gov/pubmed/22674553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3003643
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker